Navigation Links
UCB Launches CIMplicity(TM) Program to Enhance Treatment Support for Cimzia(R) (certolizumab pegol) Patients and Caregivers
Date:4/24/2008

e fungal infections, and other opportunistic infections, have been observed in patients receiving Cimzia(R). Some of these infections have been fatal. Anti-tuberculosis treatment of patients with latent tuberculosis infection reduces the risk of reactivation in patients receiving treatment with TNF blockers such as Cimzia(R). However, active tuberculosis has developed in patients receiving Cimzia whose tuberculin test was negative. Evaluate patients for tuberculosis risk factors and test for latent tuberculosis infection prior to initiating Cimzia(R) and during therapy. Initiate treatment of latent tuberculosis infection prior to therapy with Cimzia(R). Monitor patients receiving Cimzia(R) for signs and symptoms of active tuberculosis, including patients who tested negative for latent tuberculosis infection. Consider anti-tuberculosis therapy prior to initiation of Cimzia(R) in patients with a past history of latent or active tuberculosis in whom an adequate course of treatment cannot be confirmed. Serious infections, sepsis, and cases of opportunistic infections, including fatalities, have been reported in patients receiving TNF blockers, including Cimzia(R). Infections have been reported in patients receiving Cimzia(R) alone or in conjunction with immunosuppressive agents. Do not initiate treatment with Cimzia(R) in patients with active infections, including chronic or localized infections. Patients who develop a new infection while undergoing treatment with Cimzia(R) should be monitored closely. Discontinue administration of Cimzia(R) if a patient develops a serious infection. Exercise caution when considering the use of Cimzia(R) in patients with a history of recurrent infection, concomitant immunosuppressive therapy, or underlying conditions that may predispose them to infections, or patients who have resided in regions where tuberculosis and histoplasmosis are endemic.

Use of TNF blockers, including Cimzia(R), may increase the risk of reactivation of he
'/>"/>

SOURCE UCB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
2. UPMC Health Plan Launches New Personal Health Record
3. HealthInsuranceFinders.com Launches Video Contest for Young Directors
4. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
5. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
6. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
7. Mannatech Launches Phase One of New Sales and Training Tools
8. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
9. Actavis Launches Carvedilol Tablets in the U.S.
10. MedQuist Re-launches New, Improved Web Site
11. Elsevier launches new journal: Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Illinois (PRWEB) September 02, 2014 ... Chief Executive Officer and Chief Information Officer Strategy ... Carlton Chicago. , Becker's Hospital Review Chief Executive ... together hospital and health system Chief Executive Officers, ... hospital and health system executives through high-quality ...
(Date:9/2/2014)... FL (PRWEB) September 02, 2014 After respective performances ... compete against each other on September 5th at Sun Life Stadium. ... the brightest stars in the world of football in Colombian and ... some of the best talent in the world in early September. ... the world according to FIFA. The host nation of the ...
(Date:9/2/2014)... (PRWEB) September 03, 2014 Recently, iFitDress.com, ... special occasion gowns, has released its range of 2014 ... are now offered at low prices. A large proportion ... the beautiful products from iFitDress.com are carefully made by ... it also offers bachelorette party gowns, ivory satin wedding ...
(Date:9/2/2014)... BOSTON (September 2, 2014 4 pm EDT): In a ... American Medical Association , a team of Boston researchers ... improve dietary quality in the United States. The researchers ... at Tufts University, Harvard University and Boston Children,s Hospital ... subsidizing healthier foods could both help people make meaningful ...
(Date:9/2/2014)... 2014 The exciting information sessions and ... Carey Lewis and Bob Wiley. The team ... who have the desire to illuminate entertainment with the ... could be invited to join the Bridge Training ... – Saturday, Sept. 6, Charlotte Convention Center, 501 South ...
Breaking Medicine News(10 mins):Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 2Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 3Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 4Health News:Brazil Vs. Colombia Tickets in Miami at Sun Life Stadium: Dazzling Deals Tickets Advises Soccer Fans To Reserve Tickets Early for Brazil vs. Colombia Rematch in Florida 2Health News:Brazil Vs. Colombia Tickets in Miami at Sun Life Stadium: Dazzling Deals Tickets Advises Soccer Fans To Reserve Tickets Early for Brazil vs. Colombia Rematch in Florida 3Health News:Discounted Seashell Wedding Dresses Currently Provided By iFitDress.com 2Health News:Taxes and subsidies could encourage healthier diet and lower healthcare costs 2Health News:Actors, Models and Talent for Christ Auditions Are Set for Charlotte and Omaha on Saturday, September 6, 2014 2
... , NORTH DARTMOUTH, Mass., Sept. 10 The ... is now offering all sleep medicine services at one location. ... the 84 Faunce Corner Road location in North Dartmouth, MA, ... their sleep disorders. , , While at ...
... , BALTIMORE, Sept. 10 The following statement ... Addiction Treatment Gap (CATG) initiative: , , ... addiction remains at pandemic levels, with 23 million Americans suffering from ... diabetes. But you wouldn,t know it from the way our ...
... , FORT LAUDERDALE, Fla., Sept. 10 ... on the dangers of synthetic hormone replacement therapy for menopausal women, ... safer treatment option. , , A white ... , published in the October edition of Life Extension ...
... NEW YORK, Sept. 10 Reportlinker.com announces that a new ... , North America Air Purification Equipment ... http://www.reportlinker.com/p0109900/North-America-Air-Purification-Equipment-Market.html , , ... Equipment in US$ Million & Thousand Units The market is ...
... SXC Health Solutions Corp. ("SXC" or the "Company") (NASDAQ: ... of technology and pharmacy benefit management (PBM) services, announced ... to June 30, 2011, for its informedRx PBM business ... Hawaii. Under the agreement, SXC is providing full-service PBM ...
... Sept. 10 Reportlinker.com announces that a new market research ... World Botulinum Toxin Market , ... This report analyzes the worldwide markets for Botulinum ... for ,Botulinum Toxin, by the Following Segments: Cosmetic, and Therapeutic ...
Cached Medicine News:Health News:Sleep HealthCenters and Southcoast Hospitals Group Expand Patient Services in North Dartmouth 2Health News:Closing the Addiction Treatment Gap (CATG) Statement on Annual National Survey on Drug Use and Health Data Released by the Substance Abuse and Mental Health Services Administration (SAMHSA) 2Health News:Closing the Addiction Treatment Gap (CATG) Statement on Annual National Survey on Drug Use and Health Data Released by the Substance Abuse and Mental Health Services Administration (SAMHSA) 3Health News:The End of the Bio-Identical Hormone Debate 2Health News:Reportlinker Adds North America Air Purification Equipment Market Report 2Health News:Reportlinker Adds North America Air Purification Equipment Market Report 3Health News:Reportlinker Adds North America Air Purification Equipment Market Report 4Health News:Reportlinker Adds North America Air Purification Equipment Market Report 5Health News:Reportlinker Adds North America Air Purification Equipment Market Report 6Health News:Reportlinker Adds North America Air Purification Equipment Market Report 7Health News:Reportlinker Adds North America Air Purification Equipment Market Report 8Health News:Reportlinker Adds North America Air Purification Equipment Market Report 9Health News:Reportlinker Adds North America Air Purification Equipment Market Report 10Health News:Reportlinker Adds North America Air Purification Equipment Market Report 11Health News:Reportlinker Adds North America Air Purification Equipment Market Report 12Health News:Reportlinker Adds North America Air Purification Equipment Market Report 13Health News:Reportlinker Adds North America Air Purification Equipment Market Report 14Health News:Reportlinker Adds North America Air Purification Equipment Market Report 15Health News:SXC Health Solutions announces PBM contract renewal with Hawaii Employer-Union Health Benefits Trust Fund 2Health News:SXC Health Solutions announces PBM contract renewal with Hawaii Employer-Union Health Benefits Trust Fund 3Health News:SXC Health Solutions announces PBM contract renewal with Hawaii Employer-Union Health Benefits Trust Fund 4Health News:Reportlinker Adds World Botulinum Toxin Market Report 2Health News:Reportlinker Adds World Botulinum Toxin Market Report 3Health News:Reportlinker Adds World Botulinum Toxin Market Report 4Health News:Reportlinker Adds World Botulinum Toxin Market Report 5Health News:Reportlinker Adds World Botulinum Toxin Market Report 6Health News:Reportlinker Adds World Botulinum Toxin Market Report 7Health News:Reportlinker Adds World Botulinum Toxin Market Report 8Health News:Reportlinker Adds World Botulinum Toxin Market Report 9Health News:Reportlinker Adds World Botulinum Toxin Market Report 10Health News:Reportlinker Adds World Botulinum Toxin Market Report 11Health News:Reportlinker Adds World Botulinum Toxin Market Report 12
(Date:9/2/2014)... DALLAS , September 2, 2014 ... Chromatography Column Market by Type (Empty, Pre-packed, Analytical, Preparative), by Material ... Flash Chromatography, UFLC), TLC,SFC] - Forecast to 2018", published by ... Million in 2013. It is poised to grow at ... Million by 2018. Browse 90 market ...
(Date:9/2/2014)... 2014 Particle Sciences, the leading CDMO for ... development and manufacturing capabilities with the addition of a ... Particle Sciences, Associate Director Clinical Production, "The company has ... square footage, equipment and staff across the board, all ... has over 6000ft 2 of operating cleanroom and ...
(Date:9/2/2014)... , Sept. 2, 2014 /PRNewswire-iReach/ -- Ortho Development® ... Alpine™ Hip Stem, the latest addition to its ... Stem is intended for use in total hip ... http://photos.prnewswire.com/prnh/20140830/141676 Alpine was ... stem philosophy. ODEV,s engineers worked closely with a ...
Breaking Medicine Technology:Chiral Chromatography Column Market Worth $87.8 Million by 2018 2Chiral Chromatography Column Market Worth $87.8 Million by 2018 3Chiral Chromatography Column Market Worth $87.8 Million by 2018 4Particle Sciences Expands Drug Eluting Device Capabilities and Overall Clinical Trial Manufacturing Resources 2Ortho Development Receives FDA Clearance for Alpine Hip Stem 2
... 15 VION,PHARMACEUTICALS, INC. (Nasdaq: VION ) today ... to the pivotal Phase II trial of its lead ... novo poor-risk acute myelogenous leukemia (AML). Alan Kessman, ... reached this milestone in the pivotal Phase II trial ...
... Study to Explore the Efficacy of Novel Proteasome Inhibitor ... Patients with Relapsed and Refractory Multiple Myeloma, SOUTH ... Multiple Myeloma Research Consortium (MMRC) and Proteolix, Inc. today,announced ... Phase 2,clinical trial to study Proteolix,s potent and selective ...
Cached Medicine Technology:Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 2Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 3Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 4The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 2The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 3The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 4
... Lyra-i system combines the longest available wavelength ... maximize patient safety and efficacy. The unique ... the therapeutic range to all targeted structures. ... ensuring patient safety. All Lyra-I patients are ...
... The Company's Aura-i Laser System is ... designed for office-based procedures. Its unique, integrated ... benign vascular, including telangiectasia on the leg ... leg veins. It can also be used ...
Surgisis Inguinal Hernia Matrix is implanted to reinforce soft tissues in the inguinal floor to repair inguinal hernias. Supplied sterile in peel-open packages. Intended for one-time use....
Used for implantation to reinforce soft tissue in the repair of a hernia or body wall defect. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: